No matter what happens, don’t panic in these 3 growth stocks – sell


In most investment segments, a small number of winning stocks are usually the share of the outsourced stock of the overall return. To get more out of those winners, investors must resist the urge to sell early when the stock rises a lot, and instead, let their winners run.

It can be tempting to make a profit when it is fixed, and in the event of a market upheaval it can tempt your landlords to double down in the hope that it will return. However, history has shown that these tricks result in regular subprime returns and high opportunity costs. Today, let’s look at three momentum stocks that have made huge gains for shareholders over the past year and consider why investors would do well to hold on to their shares despite celebrating their paper benefits.

Excited spouses watching on the computer screen.

Image Source: Getty Images.

1. Match group

With stable of well-known brands including Tinder, Match.com, Occupied, Plenty of Fish and Hinge, Match groupNo. (Nasdaq: MTCH) The market share in the world of online dating is unmatched. In fact, the company’s various services in the U.S. Tinder and Hinge are responsible for kick-starting 6 out of 10 relationships starting online. The former is the world’s most downloaded and highest-earning dating app, and the membership has more than increased tenfold since 2017 to 4 million Is done.

The match now has 10.1 million paid subscribers on its platform, generating 2 2.2 billion in annual revenue and 8 258 million in free cash flow free cash flow (FCF). In the second quarter, its revenue rose 12% to 55 555.5 million, while its earnings per share rose 13% to $ 0.51.

Its consumer growth rate in March took a catastrophic plunge during the height of the epidemic, but it is now back to normal, a year-on-year average of more than 15% as of July 31st. Providing all growth matches, its stock has a surprisingly good value, with a price-to-sell (P / S) ratio of only 6.5. Match stock has risen more than 40% in the past year.

2. Chag

ChagNo. (NYSE: CHGG) The role of higher education has become more important than ever as universities around the world move towards teaching online learning in view of the COVID-19 epidemic. The company sells and finances writing, tutoring, assignment solutions as well as textbooks and e-books to university students. It only costs થી 15 to 20 20 per month for a Chag subscription – a relevant deal compared to the time it takes to save students using the service to help them understand difficult concepts.

During the second quarter, Chag’s revenue rose a staggering 63% year-over-year to 15 3,153 million. Net income has reached $ 10.6 million compared to the net loss of 2 2 million recorded in the Q-201 book of 2011 Q. The company added about 1.5 million subscribers during the year, bringing its total subscription to 3.7 million.

With the massive adoption of online education in 2020, Chag’s growth trajectory is probably far away. For the full year, the company expects to generate revenue of 15 615 million, up from 11 411 million last year. Since October 2019, Chag’s shares have risen more than 90%.

3. Teladok Health

August 5, Teladok Health (NYSE: TDOC) And Livongo Health (Nasdaq: LVGO) Announcing the .. 1.5..5 billion merger that will make it the largest telemedicine company in the US, so far, Teladoc has been one of the most successful virtual healthcare platforms in the nation, with an average revenue of 67% since 2001. The company expects to generate about 1 1 billion in revenue by 2020.

Teladok’s growth rate accelerated naturally with the onset of the COVID-19 epidemic, leading to increased demand for virtual doctor visits. During the second quarter, the company’s paid membership grew 92% year-over-year to 51.5 million, while total visits increased it to more than 2.8 million. Prior to the epidemic, only 11% of Americans said they were comfortable using telemedicine services. By the end of Q2, that number had reached 76%.

That’s not all: Teladok also has an impressive 90% client retention rate and generates savings of up to $ 472 per patient compared to individual visits. Similarly, iv %% patients who sign up for a paid membership for Livongo’s name application can help them save about $ 2,000 per year in medical costs; App users have reported improvement in hypertension, overweight management and quality of life.

More than 250 250 billion in U.S. annual health spending could shift to virtual service providers in the coming years, creating a significant opportunity for Teladok and Livongo. Next, both should be able to generate significant post-merger revenue synergy by encouraging their customers to sign up for both sets of service – and to reap the benefits. And they can accelerate their revenue growth by expanding their businesses internationally.

The sky is the limit for Teladok and Livongo. Management projects that the joint venture will generate અને 3.5 billion in revenue and up to 59 1591 million by 2023, excluding non-cash expenditure (EBITDA). So if you are a healthcare investor who is sitting on the profits of Teladok’s 166 health paper. % Run up in the past year, sit tight. Still to come.